Comparison between tools for measuring breathlessness: Cross-sectional validation of the Japanese version of the Dyspnoea-12

被引:5
|
作者
Nishimura, Koichi [1 ]
Oga, Toru [2 ]
Nakayasu, Kazuhito [3 ]
Taniguchi, Hiroyuki [4 ]
Ogawa, Tomoya [5 ]
Watanabe, Fumiko [5 ]
Arizono, Shinichi [6 ]
Kusunose, Masaaki [1 ]
Sanda, Ryo [1 ]
Shibayama, Ayumi [7 ]
Okamoto, Sawako [8 ]
Yorke, Janelle [9 ]
机构
[1] Natl Ctr Geriatr & Gerontol, Dept Resp Med, 7-430 Morioka Cho, Obu 4748511, Japan
[2] Kawasaki Med Sch, Dept Resp Med, Kurashiki, Okayama, Japan
[3] Kondo Photo Proc Co Ltd, Data Res Sect, Osaka, Japan
[4] Hotta Hosp, Dept Internal Med, Nagoya, Aichi, Japan
[5] Tosei Gen Hosp, Dept Rehabil, Seto, Japan
[6] Seirei Christopher Univ, Sch Rehabil Sci, Hamamatsu, Shizuoka, Japan
[7] Natl Ctr Geriatr & Gerontol, Dept Nursing, Obu, Japan
[8] Nara Med Univ, Dept Publ Hlth Hlth Management & Policy, Kashihara, Nara, Japan
[9] Univ Manchester, Div Nursing Midwifery & Social Work, Fac Biol Med & Hlth, Manchester, Lancs, England
来源
CLINICAL RESPIRATORY JOURNAL | 2021年 / 15卷 / 11期
关键词
chronic obstructive pulmonary disease (COPD); Dyspnoea-12 (D-12); Baseline Dyspnea Index and Transitional Dyspnea Index (BDI; TDI); St; George's Respiratory Questionnaire (SGRQ); LUNG; DISEASE; RELIABILITY; LIMITATION; INSTRUMENT; MANAGEMENT; EXERCISE;
D O I
10.1111/crj.13427
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction The Dyspnoea-12 (D-12) is a brief, easy to complete questionnaire for measuring breathlessness. Objectives To facilitate further efforts to measure dyspnoea in real clinical settings, the authors aimed to develop and validate a Japanese version of the D-12 and also compare the D-12 with the Baseline Dyspnea Index (BDI) and the Activity component of the St. George's Respiratory Questionnaire (SGRQ). Methods The standardized procedure in accordance with international guidelines was used to create the translation. A validation study with a cross-sectional observational design was conducted on 122 subjects with stable chronic obstructive pulmonary disease (COPD). Results The internal consistency of the D-12 was high (Cronbach's coefficient alpha = 0.883) and similar to that of the BDI (alpha = 0.824) and SGRQ Activity (alpha = 0.872). The relationships between tools were statistically significant (|R-s| = 0.53 to 0.66). Although the scores obtained from all three tools were skewed toward the milder end of the respective scales, this deviation was most prominent in the D-12 with a floor effect of 48.4%. Conclusion The Japanese version of the D-12 was successfully validated, but we should be careful of any floor effect and marked skew to the mild end of the scale, especially in subjects with mild COPD.
引用
收藏
页码:1201 / 1209
页数:9
相关论文
共 50 条
  • [1] Comparison between tools for measuring breathlessness: cross-sectional observation and predictive properties
    Kusunose, Masaaki
    Sanda, Ryo
    Narita, Ayumi
    Nishimura, Koichi
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [2] Preliminary Validation Results Of The Brazilian Version Of The Dyspnoea-12 Scale
    Baddini-Martinez, J.
    Simsic, A. A.
    Rodrigues, H. B.
    Di Lorenzo, V. A. P.
    Regueiro, E. M. G.
    Yorke, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [3] Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease
    Sundh, Josefin
    Bornefalk, Hans
    Skold, Carl Magnus
    Janson, Christer
    Blomberg, Anders
    Sandberg, Jacob
    Bornefalk-Hermansson, Anna
    Igelstrom, Helena
    Ekstrom, Magnus
    [J]. BMJ OPEN RESPIRATORY RESEARCH, 2019, 6 (01)
  • [4] Adaptation and validation of the Chinese version of Dyspnoea-12 scale in individuals with chronic obstructive pulmonary disease
    Choi, Tiffany Ching Man
    Chan, Lloyd Long Yu
    Tsang, Hin Cheung
    Vong, Yee Ping
    Cheng, Yui Kwan
    To, Yuk Ling
    Choo, Kah Lin
    Yorke, Janelle
    [J]. CLINICAL RESPIRATORY JOURNAL, 2021, 15 (10): : 1081 - 1087
  • [5] Validation of the japanese version of the sarcoidosis health questionnaire: A cross-sectional study
    Tanizawa, Kiminobu
    Handa, Tomohiro
    Nagai, Sonoko
    Oga, Toru
    Kubo, Takeshi
    Ito, Yutaka
    Watanabe, Kizuku
    Aihara, Kensaku
    Chin, Kazuo
    Mishima, Michiaki
    Izumi, Takateru
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2011, 9
  • [6] Validation of the japanese version of the sarcoidosis health questionnaire: A cross-sectional study
    Kiminobu Tanizawa
    Tomohiro Handa
    Sonoko Nagai
    Toru Oga
    Takeshi Kubo
    Yutaka Ito
    Kizuku Watanabe
    Kensaku Aihara
    Kazuo Chin
    Michiaki Mishima
    Takateru Izumi
    [J]. Health and Quality of Life Outcomes, 9
  • [7] Relationship between Loneliness and Mild Behavioral Impairment: Validation of the Japanese Version of the MBI Checklist and a Cross-Sectional Study
    Matsuoka, Teruyuki
    Ismail, Zahinoor
    Imai, Ayu
    Shibata, Keisuke
    Nakamura, Kaeko
    Nishimura, Yukihide
    Rubinstein, Ellen
    Uchida, Hiroyuki
    Mimura, Masaru
    Narumoto, Jin
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2024, 97 (04) : 1951 - 1960
  • [8] Development of the Japanese version of the Mobile Device Proficiency Questionnaire: A cross-sectional validation study
    Shimokihara, Suguru
    Tanaka, Hiroyuki
    Boot, Walter R.
    Nagata, Yuma
    Nakai, Shunsuke
    Tenjin, Masahiro
    Tabira, Takayuki
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2024,
  • [9] Validation and reliability of a Japanese version of the Shoulder Pain and Disability Index: A cross-sectional study
    Sekiguchi, Takuya
    Hagiwara, Yoshihiro
    Ando, Akira
    Kanazawa, Kenji
    Suzuki, Kazuaki
    Koide, Masashi
    Yabe, Yutaka
    Onoda, Satsuki
    Itoi, Eiji
    [J]. JOURNAL OF ORTHOPAEDIC SCIENCE, 2021, 26 (04) : 595 - 598
  • [10] Validation of the Japanese version of the barriers questionnaire II in cancer pain management: a cross-sectional study
    Naoki Sakakibara
    Hiroko Komatsu
    Mikako Takahashi
    Hideko Yamauchi
    Teruo Yamauchi
    Ardith Z. Doorenbos
    [J]. BMC Palliative Care, 19